W. D. Hooper

3.2k total citations
99 papers, 2.5k citations indexed

About

W. D. Hooper is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, W. D. Hooper has authored 99 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pediatrics, Perinatology and Child Health, 37 papers in Psychiatry and Mental health and 23 papers in Pharmacology. Recurrent topics in W. D. Hooper's work include Pharmacological Effects and Toxicity Studies (44 papers), Epilepsy research and treatment (35 papers) and Pharmacogenetics and Drug Metabolism (20 papers). W. D. Hooper is often cited by papers focused on Pharmacological Effects and Toxicity Studies (44 papers), Epilepsy research and treatment (35 papers) and Pharmacogenetics and Drug Metabolism (20 papers). W. D. Hooper collaborates with scholars based in Australia, United States and Switzerland. W. D. Hooper's co-authors include R. G. Dickinson, Mervyn J. Eadie, M. J. Eadie, Felix Bochner, J. H. Tyrer, J. H. Tyrer, John H. Tyrer, I. Bernus, James M. Sutherland and Elizabeth M. J. Gillam and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Journal of Chromatography A.

In The Last Decade

W. D. Hooper

98 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. D. Hooper Australia 28 1.2k 731 609 498 317 99 2.5k
R. G. Dickinson Australia 32 1.2k 1.0× 683 0.9× 964 1.6× 666 1.3× 569 1.8× 107 3.1k
R Gugler Germany 34 1.0k 0.9× 494 0.7× 751 1.2× 633 1.3× 694 2.2× 106 3.6k
Juliette Säwe Sweden 37 1.4k 1.2× 358 0.5× 1.5k 2.5× 664 1.3× 602 1.9× 77 4.5k
Susan M. Pond Australia 35 642 0.5× 433 0.6× 849 1.4× 641 1.3× 541 1.7× 161 4.4k
D.D. Breimer Netherlands 27 444 0.4× 231 0.3× 510 0.8× 381 0.8× 501 1.6× 89 2.4k
J. Robert Powell United States 27 628 0.5× 250 0.3× 409 0.7× 281 0.6× 358 1.1× 77 2.0k
Allen J. Sedman United States 32 513 0.4× 357 0.5× 531 0.9× 420 0.8× 661 2.1× 86 3.2k
Peter G. Dayton United States 32 449 0.4× 298 0.4× 587 1.0× 407 0.8× 554 1.7× 109 3.1k
Anthony J. Glazko United States 23 574 0.5× 207 0.3× 390 0.6× 224 0.4× 444 1.4× 59 1.9k
John M. Strong United States 30 413 0.3× 162 0.2× 546 0.9× 580 1.2× 253 0.8× 76 2.4k

Countries citing papers authored by W. D. Hooper

Since Specialization
Citations

This map shows the geographic impact of W. D. Hooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. D. Hooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. D. Hooper more than expected).

Fields of papers citing papers by W. D. Hooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. D. Hooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. D. Hooper. The network helps show where W. D. Hooper may publish in the future.

Co-authorship network of co-authors of W. D. Hooper

This figure shows the co-authorship network connecting the top 25 collaborators of W. D. Hooper. A scholar is included among the top collaborators of W. D. Hooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. D. Hooper. W. D. Hooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hooper, W. D., et al.. (2001). Evaluation of a pharmacokinetic interaction between remacemide hydrochloride and phenobarbitone in healthy males. British Journal of Clinical Pharmacology. 51(3). 249–255. 1 indexed citations
2.
Reith, David, W. D. Hooper, John Parke, & Bruce Charles. (2001). Population Pharmacokinetic Modeling of Steady State Carbamazepine Clearance in Children, Adolescents, and Adults. Journal of Pharmacokinetics and Pharmacodynamics. 28(1). 79–92. 29 indexed citations
3.
Lo, An-Ya, R. S. Addison, W. D. Hooper, & R. G. Dickinson. (2001). Disposition of naproxen, naproxen acyl glucuronide and its rearrangement isomers in the isolated perfused rat liver. Xenobiotica. 31(6). 309–319. 9 indexed citations
4.
Hooper, W. D., et al.. (2000). Apparent autoinduction of valproate β‐oxidation in humans. British Journal of Clinical Pharmacology. 49(5). 409–415. 26 indexed citations
5.
Reith, David, D. Barry Appleton, W. D. Hooper, & Mervyn J. Eadie. (2000). The effect of body size on the metabolic clearance of carbamazepine. Biopharmaceutics & Drug Disposition. 21(3). 103–111. 15 indexed citations
6.
Addison, R. S., Suzanne L. Parker, Mervyn J. Eadie, W. D. Hooper, & R. G. Dickinson. (2000). Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers. European Journal of Clinical Pharmacology. 56(9-10). 715–721. 17 indexed citations
7.
Hooper, W. D., M. E. Franklin, Paul Glue, et al.. (1996). Effect of Felbamate on Valproic Acid Disposition in Healthy Volunteers: Inhibition of β‐Oxidation. Epilepsia. 37(1). 91–97. 45 indexed citations
8.
Bernus, I., W. D. Hooper, R. G. Dickinson, & Mervyn J. Eadie. (1995). Metabolism of carbamazepine and co-administered anticonvulsants during pregnancy. Epilepsy Research. 21(1). 65–75. 18 indexed citations
9.
Bernus, I., R. G. Dickinson, W. D. Hooper, & Mervyn J. Eadie. (1994). Early stage autoinduction of carbamazepine metabolism in humans. European Journal of Clinical Pharmacology. 47(4). 355–60. 27 indexed citations
10.
Hooper, W. D., et al.. (1992). Enantioselective pharmacokinetics of ethotoin in humans following single oral doses of the racemate. Chirality. 4(3). 142–147. 9 indexed citations
11.
Hooper, W. D., et al.. (1992). Metabolism of diazepam and related benzodiazepines by human liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics. 17(1). 51–59. 17 indexed citations
12.
Hooper, W. D., M. J. Eadie, & R. G. Dickinson. (1991). Single oral dose pharmacokinetics and comparative bioavailability of danazol in humans. Biopharmaceutics & Drug Disposition. 12(8). 577–582. 13 indexed citations
13.
Hooper, W. D., et al.. (1990). The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans. Clinical Pharmacology & Therapeutics. 48(6). 633–640. 61 indexed citations
14.
Hooper, W. D., et al.. (1989). Stereoselective metabolism and pharmacokinetics of racemic methylphenobarbital in humans.. Drug Metabolism and Disposition. 17(2). 212–217. 20 indexed citations
15.
Dickinson, R. G., et al.. (1989). Urinary Excretion of Valproate and Some Metabolites in Chronically Treated Patients. Therapeutic Drug Monitoring. 11(2). 127–133. 59 indexed citations
16.
Eadie, Mervyn J., W. D. Hooper, & R. G. Dickinson. (1988). Valproate-Associated Hepatotoxicity and its Biochemical Mechanisms. PubMed. 3(2). 85–106. 95 indexed citations
17.
Dickinson, R. G., Ruth M. Kluck, Mervyn J. Eadie, & W. D. Hooper. (1985). Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis.. Journal of Pharmacology and Experimental Therapeutics. 233(1). 214–221. 14 indexed citations
18.
Hooper, W. D., Anthony M. Treston, Nina Jacobsen, R. G. Dickinson, & Mervyn J. Eadie. (1983). Identification of p-hydroxyprimidone as a minor metabolite of primidone in rat and man.. Drug Metabolism and Disposition. 11(6). 607–610. 5 indexed citations
19.
Hooper, W. D., et al.. (1981). Pharmacokinetics and Bioavailability of Methylphenobarbital in Man. Therapeutic Drug Monitoring. 3(1). 39–44. 7 indexed citations
20.
Lander, Cecilie M., et al.. (1976). The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients.. PubMed. 13. 89–96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. G. Dickinson Breakdown of academic impact, for papers by R Gugler Breakdown of academic impact, for papers by Juliette Säwe Breakdown of academic impact, for papers by Susan M. Pond Breakdown of academic impact, for papers by D.D. Breimer Breakdown of academic impact, for papers by J. Robert Powell Breakdown of academic impact, for papers by Allen J. Sedman Breakdown of academic impact, for papers by Peter G. Dayton Breakdown of academic impact, for papers by Anthony J. Glazko Breakdown of academic impact, for papers by John M. Strong
Rankless by CCL
2026